A whole body scan (FDG PET study) to learn more about cancer of the ovaries. This is to see if the cancer remains at the original site (residual), has spread to other organs (metastatic) or has returned in the original site (recurrent).
Treatment venue
Medical specialty
Your care options
Bulk billing patient:
If you are bulk billed for a medical service you will have no out-of-pocket costs. The GP or specialist bills Medicare and accepts the Medicare benefit as full payment for the service.
Non-bulk billing patient:
GPs and specialists can set a fee for the service that is higher than the Medicare benefit. In this case you may have out-of-pocket costs. This is the difference between the service fee and the Medicare benefit.
For patients who had an MBS item 61565 in a private setting across all of Western Australia, 0% had an out-of-pocket cost. Of those:
Patients typically paid: $0, Medicare paid: $860, Insurer paid: $0. Typical fees: $860.Percent of patients who paid in 2022-23
100% of patients had no out-of-pocket costs
0% of patients had out-of-pocket costs
Low, typical, and high out-of-pocket costs
Of the 0% of people who had an out-of-pocket cost in 2022-23, the typical cost was calculated as follows:
What the fees and costs shown include
The fees and costs show typical fees for an individual service. They are based on data from 2022-23.
Each service is linked to a number listed on the Medicare Benefits Schedule (MBS), called an MBS item. Patients may have other MBS items as well, as multiple services may occur in a setting. The Medicare benefit amount(opens in new tab) has been rounded to the nearest dollar.
Talk to your GP or specialist to find out:
- If you may need a referral to a medical specialist.
- What specific tests or treatments you will need. This might include diagnostic imaging or pathology services.
- What other specialists may be involved in your service, and their fees.
We show local data by Primary Health Network(opens in new tab) if a person or provider can’t be identified. Otherwise, we will show information at higher level, by aggregating the data. The data might then be at a state and territory level, or across Australia. See our disclaimer for more information.
What the fees and costs shown don’t include
- Aftercare costs.
- Costs associated with pharmaceuticals and other incidentals.
MBS item number(s) that may be the main treatment for an MBS item 61565.
A whole body scan (FDG PET study) to learn more about cancer of the ovaries. This is to see if the cancer remains at the original site (residual), has spread to other organs (metastatic) or has returned in the original site (recurrent).